(object) array( 'id' => '1461049', 'url' => 'SR/phase_iii_trials', 'image' => '', 'title' => 'Treća faza ispitivanja', 'tags' => array ( 0 => 'Treća faza ispitivanja', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'Treća faza ispitivanja', 'source_id' => 30918, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705155511', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Proširena kontrolisana i nekontrolisana ispitivanja posle preliminarne evidencije kojom je postignuta efikasnost leka i kojom se namerava prikupljanje dodatnih informacija za procenu sveukupnog odnosa korist-rizik leka i omogući adekvatna osnova za lekara opšte prakse.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966432247812, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'phase iii trials', 'Definition' => 'Expanded controlled and uncontrolled trials after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug and provide and adequate basis for physician labeling.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'phase_iii_trials', )

(object) array( 'id' => '1461088', 'url' => 'SR/convention_₅', 'image' => '', 'title' => 'konvencija', 'tags' => array ( 0 => 'konvencija', 1 => 'Language', 2 => 'Terminology', 3 => '', ), 'term' => 'konvencija', 'source_id' => 1080723, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Language', ), 'category' => array ( 0 => 'Terminology', ), 'lastedit' => '20110705163519', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Sporazum, uglavnom jednosglasno postignut od strane govornika zajednice, da se povezanost mora primenjivati između lingvističkih jedinica, između ovih i dpoljnog sveta ili primeniti pri upotrebi gramatičkih pravila datij jezika.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966616797187, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'convention', 'Definition' => 'An agreement, usually reached unconsciously by speakers in a community, that relationships are to apply between linguistic items, between these and the outside world or to apply in the use of rules in the grammar of their language.', 'Part of Speech' => 'noun', 'Usage Status' => 'New', 'Industry' => 'Language', 'Product Category' => 'Terminology', 'Creation User' => 'nunk0410', 'Creation Date' => '2011/4/17', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'convention_₅', )

(object) array( 'id' => '1467622', 'url' => 'SR/Food_and_Drug_Administration', 'image' => '', 'title' => 'Administraija za hranu i lekove', 'tags' => array ( 0 => 'Administraija za hranu i lekove', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'Administraija za hranu i lekove', 'source_id' => 30899, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110709203524', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Deo američkog Zavoda za Zdravlje i Zdravstvene Usluge odgovoran za obezbeđivanje bezbednosti i efikasnosti svih lekova, bioloških preparata, vakcina i medicinskih sredstava, uključujući one koji se koriste u dijagnostici, lečenju i prevenciji HIV-a, AIDS-a ili oportunističkih infekcija uzrokovanih AIDS-om. Administracija za hranu i lekove (FDA)takođe sarađuje sa industrijom banaka krvi u cilju obezbeđivanja zaliha krvi naciji. Internet adresa', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603999168790529, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'Food and Drug Administration', 'Definition' => 'The U.S. Department of Health and Human Services agency responsible for ensuring the safety and effectiveness of all drugs, biologics, vaccines, and medical devices, including those used in the diagnosis, treatment, and prevention of HIV infection, AIDS, and AIDS-related opportunistic infections. The FDA also works with the blood banking industry to safeguard the nation\'s blood supply. Internet address', 'Synonym' => 'FDA_₀', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'Food_and_Drug_Administration', )

(object) array( 'id' => '1467655', 'url' => 'SR/Lamictal', 'image' => '', 'title' => 'Lamictal', 'tags' => array ( 0 => 'Lamictal', 1 => 'Pharmaceutical', 2 => '', ), 'term' => 'Lamictal', 'source_id' => 31148, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'lastedit' => '20110709210502', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'lek koji se koristi u lečenju epilepsije', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603999385845761, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'Lamictal', 'Definition' => 'a prescription drug used to treat epilepsy', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Industry' => 'Pharmaceutical', 'Revision User' => 'PetriDish', 'Revision Date' => '2010/05/26', 'Creation User' => 'PetriDish', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'Lamictal', )

(object) array( 'id' => '1461087', 'url' => 'SR/linguistic_determinism', 'image' => '', 'title' => 'lingistički determinizam', 'tags' => array ( 0 => 'lingistički determinizam', 1 => 'Language', 2 => 'Terminology', 3 => '', ), 'term' => 'lingistički determinizam', 'source_id' => 1085321, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Language', ), 'category' => array ( 0 => 'Terminology', ), 'lastedit' => '20110705163518', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Odnosi se na tezu, postavljenu od strane Edvarada Sapira i Bendžamina Li Vorfa, da jezik određuje način na koji ljudi misle. Takođe se naziva hipoteza lingvističke relativnosti', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966616797186, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'linguistic determinism', 'Definition' => 'Refers to the view, propounded by Edward Sapir and Benjamin Lee Whorf, that language determines the way in which people think. Also termed the linguistic relativity hypothesis.', 'Part of Speech' => 'noun', 'Usage Status' => 'New', 'Industry' => 'Language', 'Product Category' => 'Terminology', 'Creation User' => 'nunk0410', 'Creation Date' => '2011/4/18', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'linguistic_determinism', )

(object) array( 'id' => '1461317', 'url' => 'SR/market_entry', 'image' => '', 'title' => 'ulazak na tržište', 'tags' => array ( 0 => 'ulazak na tržište', 1 => 'Business services', 2 => 'Marketing', 3 => '', ), 'term' => 'ulazak na tržište', 'source_id' => 54584, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Business services', ), 'category' => array ( 0 => 'Marketing', ), 'lastedit' => '20110705225503', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Pokušaj kompanije da uđe na tržište preko inovacija, javne nabavke ili ekspanzijeć', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603967783862276, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'market entry', 'Definition' => 'An attempt by a company to enter a market through innovation, acquisition or expansion.', 'Domain' => 'Documentation', 'Industry' => 'Business services', 'Part of Speech' => 'noun', 'Product Category' => 'Marketing', 'Usage Status' => 'New', 'Revision User' => 'Acrovo', 'Revision Date' => '2010/6/17', 'Creation User' => 'Acrovo', 'Creation Date' => '2010/6/17', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'market_entry', )

(object) array( 'id' => '1467656', 'url' => 'SR/Lamisil', 'image' => '', 'title' => 'Lamisil', 'tags' => array ( 0 => 'Lamisil', 1 => 'Pharmaceutical', 2 => '', ), 'term' => 'Lamisil', 'source_id' => 31149, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'lastedit' => '20110709210504', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'antibiotik koji se koristi u lečenju gljivičnog oboljenja noktiju na prstima stopala', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603999385845762, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'Lamisil', 'Definition' => 'an antibiotic used to treat toenail fungus', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Industry' => 'Pharmaceutical', 'Revision User' => 'PetriDish', 'Revision Date' => '2010/05/26', 'Creation User' => 'PetriDish', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'Lamisil', )

(object) array( 'id' => '1461006', 'url' => 'SR/orphan_drugs', 'image' => '', 'title' => 'lekovi ,,siročići\'\'', 'tags' => array ( 0 => 'lekovi ,,siročići\'\'', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'lekovi ,,siročići\'\'', 'source_id' => 30914, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705152503', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Kategorija Administracije za hranu i lekove koja se odnosi na lekove koji se koriste u lečenju retkih bolesti i stanja. Slabo ima finansijske motivacije za farmaceutsku industriju u pogčedu razvoja lekova za ovakve bolesti i stanja. Status lekova ,,siročića\'\', u svakom slučaju daje proizvođaču posebnu finansijsku motivaciju za razvoj i obezbeđivanje takvih lekova.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966424907780, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'orphan drugs', 'Definition' => 'An FDA category that refers to medications used to treat diseases and conditions that occur rarely. There is little financial incentive for the pharmaceutical industry to develop medications for these diseases or conditions. Orphan drug status, however, gives a manufacturer specific financial incentives to develop and provide such medications.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'orphan_drugs', )

(object) array( 'id' => '1460561', 'url' => 'SR/thrombolytic_therapy', 'image' => '', 'title' => 'trombolitička terapija', 'tags' => array ( 0 => 'trombolitička terapija', 1 => 'Pharmaceutical', 2 => 'Drugs', 3 => '', ), 'term' => 'trombolitička terapija', 'source_id' => 1047729, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Drugs', ), 'lastedit' => '20110705074502', 'part_of_speech' => 'other', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Upotreba lekova u cilju razbijanja ili rastvaranja krvnih ugrušaka, koji su glavni uzrok i srčanog i moždanog udara.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603964533276677, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'thrombolytic therapy', 'Definition' => 'Use of drugs to break up or dissolve blood clots, which are the main cause of both heart attacks and stroke.', 'Part of Speech' => 'other', 'Usage Status' => 'New', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Drugs', 'Creation User' => 'CCTRADUCTION', 'Creation Date' => '2011/4/13', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'thrombolytic_therapy', )

(object) array( 'id' => '1461055', 'url' => 'SR/side_effects', 'image' => '', 'title' => 'neželjena dejstva', 'tags' => array ( 0 => 'neželjena dejstva', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'neželjena dejstva', 'source_id' => 30937, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705160004', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Sva neželjena dejstva ili uticaji leka ili lečenja. Negativna ili štetna dejstva mogu podrazumevati glavobolju, mučninu, opadanje kose, iritaciju kože ili druge fizičke probleme. Mora se odmah izvršiti procena i trenutnih i dugotrajnih neželjenih dejstava eksperimentalnog leka.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966611554304, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'side effects', 'Definition' => 'Any undesired actions or effects of a drug or treatment. Negative or adverse effects may include headache, nausea, hair loss, skin irritation, or other physical problems. Experimental drugs must be evaluated for both immediate and long-term side effects.', 'Synonym' => 'adverse_reaction', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'side_effects', )